TEVA.TA Overview

Company Profile

Related stocks

TEVA • Israel

Teva Pharmaceutical Industries

41.1 USD

47.93B USD 1Y +94.2%

MRK.DE • Germany

MERCK KGAA I

137.85 EUR

67.16B USD 1Y +13%

ZTS • United States

Zoetis Inc.

74.81 USD

30.91B USD 1Y -49.1%

SDZ.SW • Switzerland

SANDOZ GROUP N

69.72 CHF

36.35B USD 1Y +40.9%

APN.JO • South Africa

Aspen Pharmacare Hldgs Ltd

15,826 ZAc

4.15B USD 1Y +65.2%

VTRS • United States

Viatris Inc.

17.64 USD

20.26B USD 1Y +74.9%

HLN.L • United Kingdom

HALEON PLC ORD GBP0.01

349.2 GBp

40.64B USD 1Y +1%

3692.HK • China

HANSOH PHARMA

31.54 HKD

24.37B USD 1Y -14.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Israel

Region

Africa & Middle East

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

44.2% p.a.

Max Drawdown (5Y)

-40.5%

Sharpe Ratio (5Y)

0.60

Beta Factor

0.82

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 218%.

🔴 High valuation risk: Avg P/E of 62.8 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.2% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -87.4% in the extended horizon.